• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有结合过程的自由能景观 Huperzine A 到乙酰胆碱酯酶。

Free energy landscape for the binding process of Huperzine A to acetylcholinesterase.

机构信息

Department of Engineering Mechanics, State Key Laboratory of Structural Analysis for Industrial Equipment, and Faculty of Chemical, Environmental, and Biological Science and Technology, Dalian University of Technology, Dalian 116023, China.

出版信息

Proc Natl Acad Sci U S A. 2013 Mar 12;110(11):4273-8. doi: 10.1073/pnas.1301814110. Epub 2013 Feb 25.

DOI:10.1073/pnas.1301814110
PMID:23440190
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3600462/
Abstract

Drug-target residence time (t = 1/k(off), where k(off) is the dissociation rate constant) has become an important index in discovering better- or best-in-class drugs. However, little effort has been dedicated to developing computational methods that can accurately predict this kinetic parameter or related parameters, k(off) and activation free energy of dissociation (ΔG(off)≠). In this paper, energy landscape theory that has been developed to understand protein folding and function is extended to develop a generally applicable computational framework that is able to construct a complete ligand-target binding free energy landscape. This enables both the binding affinity and the binding kinetics to be accurately estimated. We applied this method to simulate the binding event of the anti-Alzheimer's disease drug (-)-Huperzine A to its target acetylcholinesterase (AChE). The computational results are in excellent agreement with our concurrent experimental measurements. All of the predicted values of binding free energy and activation free energies of association and dissociation deviate from the experimental data only by less than 1 kcal/mol. The method also provides atomic resolution information for the (-)-Huperzine A binding pathway, which may be useful in designing more potent AChE inhibitors. We expect this methodology to be widely applicable to drug discovery and development.

摘要

药物-靶标停留时间(t = 1/k(off),其中 k(off)是离解速率常数)已成为发现更好或最佳类药物的重要指标。然而,很少有人致力于开发能够准确预测该动力学参数或相关参数 k(off)和离解自由能(ΔG(off)≠)的计算方法。在本文中,我们扩展了用于理解蛋白质折叠和功能的能量景观理论,以开发一种普遍适用的计算框架,该框架能够构建完整的配体-靶标结合自由能景观。这使得结合亲和力和结合动力学都能够被准确地估计。我们将该方法应用于模拟抗阿尔茨海默病药物(-)-石杉碱 A 与其靶标乙酰胆碱酯酶(AChE)的结合事件。计算结果与我们同时进行的实验测量非常吻合。所有预测的结合自由能和结合与离解的自由能都与实验数据的偏差小于 1 kcal/mol。该方法还为(-)-石杉碱 A 的结合途径提供了原子分辨率的信息,这可能有助于设计更有效的 AChE 抑制剂。我们希望这种方法能够广泛应用于药物发现和开发。

相似文献

1
Free energy landscape for the binding process of Huperzine A to acetylcholinesterase.具有结合过程的自由能景观 Huperzine A 到乙酰胆碱酯酶。
Proc Natl Acad Sci U S A. 2013 Mar 12;110(11):4273-8. doi: 10.1073/pnas.1301814110. Epub 2013 Feb 25.
2
Binding of huperzine A and galanthamine to acetylcholinesterase, based on ONIOM method.基于 ONIOM 方法的石杉碱甲和加兰他敏与乙酰胆碱酯酶的结合。
Nanomedicine. 2011 Feb;7(1):60-8. doi: 10.1016/j.nano.2010.08.004. Epub 2010 Sep 21.
3
Discovery of Novel Acetylcholinesterase Inhibitors as Potential Candidates for the Treatment of Alzheimer's Disease.发现新型乙酰胆碱酯酶抑制剂作为治疗阿尔茨海默病的潜在候选药物。
Int J Mol Sci. 2019 Feb 25;20(4):1000. doi: 10.3390/ijms20041000.
4
Tacrine-huperzine A hybrids (huprines): a new class of highly potent and selective acetylcholinesterase inhibitors of interest for the treatment of Alzheimer's disease.他克林-石杉碱甲杂合物(石杉碱类):一类新型高效且具有选择性的乙酰胆碱酯酶抑制剂,有望用于治疗阿尔茨海默病。
Mini Rev Med Chem. 2001 Jul;1(2):163-74. doi: 10.2174/1389557013406972.
5
Interactions of Lycopodium alkaloids with acetylcholinesterase investigated by 1H NMR relaxation rate.通过¹H NMR弛豫速率研究石松生物碱与乙酰胆碱酯酶的相互作用。
Biophys Chem. 2007 Sep;129(2-3):212-7. doi: 10.1016/j.bpc.2007.05.020. Epub 2007 Jun 7.
6
X-ray structures of Torpedo californica acetylcholinesterase complexed with (+)-huperzine A and (-)-huperzine B: structural evidence for an active site rearrangement.与(+)-石杉碱甲和(-)-石杉碱乙复合的加州电鳐乙酰胆碱酯酶的X射线结构:活性位点重排的结构证据。
Biochemistry. 2002 Sep 3;41(35):10810-8. doi: 10.1021/bi020151+.
7
Huperzine a as potential treatment of Alzheimer's disease: an assessment on chemistry, pharmacology, and clinical studies.石杉碱甲治疗阿尔茨海默病的潜力:化学、药理学和临床研究评估。
Chem Biodivers. 2011 Jul;8(7):1189-204. doi: 10.1002/cbdv.201000269.
8
Kinetics of Huperzine A Dissociation from Acetylcholinesterase via Multiple Unbinding Pathways.通过多种离解途径研究石杉碱甲从乙酰胆碱酯酶上的离解动力学。
J Chem Theory Comput. 2018 Jun 12;14(6):2843-2851. doi: 10.1021/acs.jctc.8b00173. Epub 2018 May 24.
9
Identification of Potent Acetylcholinesterase Inhibitors as New Candidates for Alzheimer Disease via Virtual Screening, Molecular Docking, Dynamic Simulation, and Molecular Mechanics-Poisson-Boltzmann Surface Area Calculations.通过虚拟筛选、分子对接、动态模拟和分子力学-泊松-波尔兹曼表面积计算鉴定潜在的乙酰胆碱酯酶抑制剂作为阿尔茨海默病的新候选药物。
Molecules. 2024 Mar 10;29(6):1232. doi: 10.3390/molecules29061232.
10
Molecular modeling of multi-target analogs of huperzine A and applications in Alzheimer's disease.石杉碱甲多靶标类似物的分子建模及其在阿尔茨海默病中的应用。
J Mol Model. 2024 Jun 8;30(7):200. doi: 10.1007/s00894-024-05991-4.

引用本文的文献

1
A Supramolecular Material for Controlling Kiwifruit Bacterial Canker.一种用于防治猕猴桃细菌性溃疡病的超分子材料。
Adv Sci (Weinh). 2025 Aug;12(31):e14752. doi: 10.1002/advs.202414752. Epub 2025 May 24.
2
MAI-TargetFisher: A proteome-wide drug target prediction method synergetically enhanced by artificial intelligence and physical modeling.MAI-TargetFisher:一种通过人工智能和物理建模协同增强的全蛋白质组药物靶点预测方法。
Acta Pharmacol Sin. 2025 May;46(5):1462-1475. doi: 10.1038/s41401-024-01444-z. Epub 2025 Jan 27.
3
Bioinformatics and computational studies of chabamide F and chabamide G for breast cancer and their probable mechanisms of action.夏马酰胺 F 和夏马酰胺 G 的生物信息学和计算研究及其对乳腺癌的可能作用机制。
Sci Rep. 2024 Aug 27;14(1):19893. doi: 10.1038/s41598-024-70854-0.
4
Accurate Characterization of Binding Kinetics and Allosteric Mechanisms for the HSP90 Chaperone Inhibitors Using AI-Augmented Integrative Biophysical Studies.使用人工智能增强的综合生物物理研究准确表征HSP90伴侣蛋白抑制剂的结合动力学和变构机制
JACS Au. 2024 Apr 1;4(4):1632-1645. doi: 10.1021/jacsau.4c00123. eCollection 2024 Apr 22.
5
Perspectives on Ligand/Protein Binding Kinetics Simulations: Force Fields, Machine Learning, Sampling, and User-Friendliness.配体/蛋白质结合动力学模拟的观点:力场、机器学习、采样和用户友好性。
J Chem Theory Comput. 2023 Sep 26;19(18):6047-6061. doi: 10.1021/acs.jctc.3c00641. Epub 2023 Sep 1.
6
Binding Kinetics Toolkit for Analyzing Transient Molecular Conformations and Computing Free Energy Landscapes.用于分析瞬态分子构象和计算自由能景观的结合动力学工具包。
J Phys Chem A. 2022 Nov 24;126(46):8761-8770. doi: 10.1021/acs.jpca.2c05499. Epub 2022 Nov 8.
7
Determination of Multidirectional Pathways for Ligand Release from the Receptor: A New Approach Based on Differential Evolution.从受体上确定配体释放的多向途径:一种基于差分进化的新方法。
J Chem Theory Comput. 2022 Jun 14;18(6):3860-3872. doi: 10.1021/acs.jctc.1c01158. Epub 2022 May 5.
8
Network Pharmacology-Based and Experimental Identification of the Effects of Paeoniflorin on Major Depressive Disorder.基于网络药理学及实验鉴定芍药苷对重度抑郁症的作用
Front Pharmacol. 2022 Feb 2;12:793012. doi: 10.3389/fphar.2021.793012. eCollection 2021.
9
A VDAC1-mediated NEET protein chain transfers [2Fe-2S] clusters between the mitochondria and the cytosol and impacts mitochondrial dynamics.VDAC1 介导的 NEET 蛋白在线粒体和细胞质之间转移 [2Fe-2S] 簇,并影响线粒体动力学。
Proc Natl Acad Sci U S A. 2022 Feb 15;119(7). doi: 10.1073/pnas.2121491119.
10
Computational Methods for Structure-Based Drug Design Through System Biology.基于系统生物学的结构导向药物设计的计算方法。
Methods Mol Biol. 2022;2385:161-174. doi: 10.1007/978-1-0716-1767-0_9.

本文引用的文献

1
New technologies in computer-aided drug design: Toward target identification and new chemical entity discovery.计算机辅助药物设计中的新技术:迈向靶点识别与新化学实体发现
Drug Discov Today Technol. 2006 Autumn;3(3):307-13. doi: 10.1016/j.ddtec.2006.09.004.
2
Computational drug discovery.计算药物发现。
Acta Pharmacol Sin. 2012 Sep;33(9):1131-40. doi: 10.1038/aps.2012.109. Epub 2012 Aug 27.
3
Binding kinetics and mechanism of action: toward the discovery and development of better and best in class drugs.结合动力学和作用机制:为了发现和开发更好和同类最佳的药物。
Expert Opin Drug Discov. 2010 Nov;5(11):1023-9. doi: 10.1517/17460441.2010.520700. Epub 2010 Sep 16.
4
The dynamics of drug-target interactions: drug-target residence time and its impact on efficacy and safety.药物-靶标相互作用的动力学:药物-靶标停留时间及其对疗效和安全性的影响。
Expert Opin Drug Discov. 2010 Apr;5(4):305-10. doi: 10.1517/17460441003677725.
5
Specificity quantification of biomolecular recognition and its implication for drug discovery.生物分子识别的特异性定量及其对药物发现的意义。
Sci Rep. 2012;2:309. doi: 10.1038/srep00309. Epub 2012 Mar 12.
6
A very short history of structure-based design: how did we get here and where do we need to go?基于结构的设计简史:我们如何走到今天,又需要走向何方?
J Comput Aided Mol Des. 2012 Jan;26(1):13-4. doi: 10.1007/s10822-011-9518-x. Epub 2011 Dec 11.
7
Pathway and mechanism of drug binding to G-protein-coupled receptors.药物与 G 蛋白偶联受体结合的途径和机制。
Proc Natl Acad Sci U S A. 2011 Aug 9;108(32):13118-23. doi: 10.1073/pnas.1104614108. Epub 2011 Jul 21.
8
Complete reconstruction of an enzyme-inhibitor binding process by molecular dynamics simulations.通过分子动力学模拟完整重建酶抑制剂结合过程。
Proc Natl Acad Sci U S A. 2011 Jun 21;108(25):10184-9. doi: 10.1073/pnas.1103547108. Epub 2011 Jun 6.
9
The free energy landscape of small molecule unbinding.小分子结合物的自由能景观。
PLoS Comput Biol. 2011 Feb;7(2):e1002002. doi: 10.1371/journal.pcbi.1002002. Epub 2011 Feb 3.
10
Mechanisms of protein-ligand association and its modulation by protein mutations.蛋白质-配体结合的机制及其通过蛋白质突变的调节。
Biophys J. 2011 Feb 2;100(3):701-710. doi: 10.1016/j.bpj.2010.12.3699.